Skin cancer is cancer of the skin! Therefore, dermatologists should be in the lead of the care of (most) skin cancer patients, which requires well developed surgical skills including MMS. The preferred treatment of high risk and/or recurrent BCCs is MMS.
In contrast to the US and Australia, the availability of MMS in Europe is very limited. We want to expand the number of European Mohs surgeons and offer the best possible care for our skin cancer patients.
The Erasmus MC (Rotterdam, The Netherlands) is among the largest MMS centers in Europe. We perform approximately 1750 MMS procedures annually and have a formal certified training program for MMS.
Professor Tamar Nijsten and his faculty are offering a 6 month EADV sponsored MMS fellowship to a highly motivated dermatologist.
Applications will open in April 2019.